Skip to main content

LifeMD Stock Forecast, Price & News

+1.86 (+28.57 %)
(As of 05/14/2021 01:45 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume153,721 shs
Average Volume1.15 million shs
Market Capitalization$219.05 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive LFMD News and Ratings via Email

Sign-up to receive the latest news and ratings for LifeMD and its competitors with MarketBeat's FREE daily newsletter.

About LifeMD

LifeMD, Inc. operates as an online direct-to-patient marketing and telemedicine company with a portfolio of health and wellness brands in the United States. It offers ShapiroMD, a medical device for male and female hair loss; RexMD, a men's telehealth brand offering virtual medical treatment from licensed providers for a variety of men's health needs; Nava MD, a female-oriented tele-dermatology and skincare brand that will offer virtual medical treatment from dermatologists and other providers; and iNR Wellness MD, a supplement for immune and digestive support. The company also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents; and LifeMD, a cash-pay subscription-based concierge care service. Its products are marketed and sold directly to consumers through advertisements on Facebook, Google, Amazon, and other social media and e-commerce platforms, as well as third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is based in New York, New York.


See More Headlines

Industry, Sector and Symbol

Industry Pharmaceutical Retailers
Current SymbolNASDAQ:LFMD
Phone866 351 5907
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Market Cap$219.05 million
Next Earnings Date8/16/2021 (Estimated)


Overall MarketRank

0.33 out of 5 stars

Medical Sector

1804th out of 2,039 stocks

Pharmaceutical Retailers Industry

10th out of 10 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

LifeMD (NASDAQ:LFMD) Frequently Asked Questions

What stocks does MarketBeat like better than LifeMD?

Wall Street analysts have given LifeMD a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but LifeMD wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is LifeMD's next earnings date?

LifeMD is scheduled to release its next quarterly earnings announcement on Monday, August 16th 2021.
View our earnings forecast for LifeMD

How were LifeMD's earnings last quarter?

LifeMD, Inc. (NASDAQ:LFMD) announced its earnings results on Sunday, March, 28th. The company reported ($2.56) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.27) by $2.29. The firm earned $12.89 million during the quarter, compared to analyst estimates of $13.62 million.
View LifeMD's earnings history

What guidance has LifeMD issued on next quarter's earnings?

LifeMD issued an update on its FY 2021 earnings guidance on Thursday, May, 13th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $90 million-$100 million, compared to the consensus revenue estimate of $87.78 million.

Who are LifeMD's key executives?

LifeMD's management team includes the following people:
  • Mr. Justin Schreiber, Pres, CEO & Chairman (Age 38, Pay $52k)
  • Mr. Stefan Galluppi, CTO & Director (Age 34, Pay $111k)
  • Mr. Juan Manuel Piñeiro Dagnery, Chief Revenue Officer (Age 33, Pay $111.97k)
  • Mr. Sean Fitzpatrick, Pres of LegalSimpli Software LLC (Age 38, Pay $119.27k)
  • Mr. Marc Benathen, Chief Financial Officer (Age 40)
  • Mr. Brad Michael Roberts, Chief Operating Officer (Age 40)
  • Mr. Eric H. Yecies, Chief Compliance Officer & Gen. Counsel (Age 42)
  • Dr. Joseph V. DiTrolio, Chief Medical Officer of US & Independent Director (Age 70)
  • Mr. Bryant Patrick Hussey, Chief Digital Officer
  • Dr. Anthony David Puopolo II, Chief Medical Officer

Who are some of LifeMD's key competitors?

What is LifeMD's stock symbol?

LifeMD trades on the NASDAQ under the ticker symbol "LFMD."

Who are LifeMD's major shareholders?

LifeMD's stock is owned by a number of retail and institutional investors. Top institutional investors include BlackRock Inc. (1.36%), Magnus Financial Group LLC (0.61%), Geode Capital Management LLC (0.59%), Monashee Investment Management LLC (0.58%), Belvedere Trading LLC (0.33%) and Northern Trust Corp (0.13%).
View institutional ownership trends for LifeMD

Which institutional investors are buying LifeMD stock?

LFMD stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Magnus Financial Group LLC, Geode Capital Management LLC, Monashee Investment Management LLC, Belvedere Trading LLC, Northern Trust Corp, Granite Investment Advisors LLC, and Rafferty Asset Management LLC.
View insider buying and selling activity for LifeMD
or or view top insider-buying stocks.

How do I buy shares of LifeMD?

Shares of LFMD can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is LifeMD's stock price today?

One share of LFMD stock can currently be purchased for approximately $8.05.

How much money does LifeMD make?

LifeMD has a market capitalization of $210.68 million.

How many employees does LifeMD have?

LifeMD employs 56 workers across the globe.

What is LifeMD's official website?

The official website for LifeMD is

How can I contact LifeMD?

The company can be reached via phone at 866 351 5907.

This page was last updated on 5/14/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.